Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. 3 Insider Initial Statement of Ownership
  2. EFFECT Other Notice of Effectiveness
  3. 8-K Event Executive or director change
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. S-3 Offering Registration Statement
  7. 4 Insider Changes in Ownership
  8. 144 Insider Sale of Securities
  9. EFFECT Other Notice of Effectiveness
  10. POS AM Other Post-effective Amendment for Registration Statement
  11. 4 Insider Changes in Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 424B3 Offering Prospectus
  20. 10-Q Report Quarterly Report

Page 12 of 19 · 362 filings